Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity
While FDA-guidelines are critical for understanding GLP-1 eligibility, there are a number of other factors to consider for determining GLP-1 eligibility
PS: My only recommendation is that you try it for more than 30 days
Cautions include history of pancreatitis, gallbladder disease, and diabetic retinopathy (particularly with semaglutide)
a G protein-coupled receptor) agonist exendin-4 suppressed -aminobutyric acid receptor (GABAR)-mediated currents through GLP-1Rs in isolated rat retinal ganglion cells (GCs)
These pathways are often reviewed in laboratory models involving metabolic signalling, receptor interaction, glucose response, energy balance and appetite-related signalling